Stratvocate offers a wealth of information and easy-to-use tools for those involved in federal contracting.

Subject: Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.
Solicitation Number: 75N98026Q00392
Notice Type: PRESOL
NAICS: 622110
Set-Aside: No Set aside used
Notice Published: 05-19-26
Response Due: 06-03-26

Agency: Department of Health and Human Services
Office: NATIONAL INSTITUTES OF HEALTH
Contact: FALZONE, MICHAEL L This email address is being protected from spambots. You need JavaScript enabled to view it.
Office Address: BETHESDA, MD 20892
Place of Performance: Bethesda, MD 20892


Click for official SAM (FBO) notice, additional information, and accompanying attachments

Attachment: Notice of Intent to Sole Source